Reversing imatinib⇔s immunosuppressive effects by modulating type I IFN signaling

David A. Largaespada

Research output: Contribution to journal › Short survey › peer-review

Fingerprint

Dive into the research topics of 'Reversing imatinib⇔s immunosuppressive effects by modulating type I IFN signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences